文献速递主动脉疾病

EVAR术中联合NBCA注射预防II型内漏

Endovascular Aortic Aneurysm Repair without Type 2 Endoleak Using Concomitant N-Butyl-2-Cyanoacrylate Injection into the Abdominal Aortic Aneurysm Sac.
PubMed 文献 · Ann Vasc Surg · 2019-12-18

本研究评估EVAR术中向动脉瘤囊内注射NBCA闭塞目标腰动脉以预防II型内漏(T2E)的新方法。结果显示治疗组术后7天T2E发生率显著低于对照组(2.4% vs 22.6%,P<0.001),12个月AAA囊直径平均缩小6.6 mm vs 4.4 mm(P=0.026),多因素分析中NBCA注射与T2E减少(OR=11.8,P<0.001)及囊直径缩小(P<0.001)显著相关,且无NBCA注射相关并发症和再干预。结论认为NBCA注射可能安全有效地减少T2E发生并预防AAA囊扩张。

要点

  • EVAR术中NBCA注射使术后7天T2E发生率从22.6%降至2.4%(P<0.001)。
  • NBCA注射组12个月AAA囊直径平均缩小6.6 mm,优于对照组的4.4 mm(P=0.026)。
  • 治疗组无NBCA注射相关并发症和再干预。

核心结论

  • NBCA注射可能安全有效地减少T2E发生并预防AAA囊扩张。

研究设计与样本

  • 回顾性研究,纳入2013-2018年176例接受EVAR的AAA患者。

主要发现

  • 治疗组术后7天T2E发生率为2.4%,对照组为22.6%(P<0.001)。
  • 治疗组12个月AAA囊直径平均缩小6.6 mm,对照组平均缩小4.4 mm(P=0.026)。
  • 多因素分析显示NBCA注射与7天T2E发生率降低显著相关(OR=11.8,P<0.001),与12个月AAA囊直径缩小显著相关(P<0.001)。
  • 治疗组无NBCA注射相关并发症和再干预。

临床怎么用

  • EVAR术中可考虑联合NBCA注射以降低T2E发生率和预防AAA囊扩张。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to evaluate our new method to occlude target lumber arteries using N-butyl-2-cyanoacrylate (NBCA) during endovascular aneurysm repair (EVAR) for prevention of type 2 endoleak (T2E). METHODS AND RESULTS: Between 2013 and 2018, 176 patients who underwent EVAR for abdominal aortic aneurysm (AAA) were reviewed. Starting from October 2015, 83 patients (treatment group) underwent NBCA injection into the aneurysmal sac during EVAR. The incidence of T2E at 7 days and AAA sac diameter 12 months after EVAR were compared with those of the control group comprising 93 consecutive patients who underwent EVAR alone before 2015. The incidence of T2E at 7 days was significantly lower in the treatment group (2.4%) than in the control group (22.6%) (P < 0.001). AAA sac diameter at 12 months in the treatment group had a mean decrease of 6.6 mm as compared with the mean 4.4 mm in the control group (P = 0.026). In multivariate analysis, NBCA injection was significantly related to the reduction of incidence of T2E at 7 days (odds ratio = 11.8, P < 0.001) and a decrease in AAA sac diameter at 12 months (P < 0.001). There was no NBCA injection-related complication and reintervention in the treatment group. CONCLUSIONS: NBCA injection might be safe and useful to reduce the incidence of T2Es and to prevent AAA sac expansion.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Miura S, Kurimoto Y, Maruyama R, et al. Endovascular Aortic Aneurysm Repair without Type 2 Endoleak Using Concomitant N-Butyl-2-Cyanoacrylate Injection into the Abdominal Aortic Aneurysm Sac. Ann Vasc Surg. 2019. PMID: 31863949. doi:10.1016/j.avsg.2019.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。